Become a donor or member and support our work to advance access to medicines. For everyone. Everywhere
News
2022
Annual Report 2021
Interpreting the EU Artificial Intelligence Act for the Health Sector
Pooled Procurement of Insulin & Associated Supplies
2021
Report – Community Engagement Meeting on Snakebite Envenoming
Procurement of Insulins & Associated Supplies
Medicine Pricing and Access in Europe
Regulatory Profile for Glucose Self-monitoring Tools
Diabetes Self-Monitoring Devices in LMICs
Eudamed and CTIS: Lessons from EudraCT
Transparency and Medicines Policy in the EU
Missing clinical trial data in Europe
Statement to the 23rd WHO Expert Committee on the Selection and Use of Essential Medicines
Statement to WHA74 on GSPOA
Statement to WHA74 on Diabetes and Access to Insulin
Response to the Revision of the EU General Pharmaceuticals Legislation
HAI Statement on The Oslo Medicines Initiative at the WHO Virtual Consultation with Non-State Actors, 31 March 2021
Response to EU’s HERA Initiative Consultation
Transparency, Accountability and Access to Medicines: European Projects 2021
How the Netherlands and other EU Governments Respond to the Challenge of Sustainable Access to Medicines
Statement to EB148 on WHO reform: involvement of non-State actors in WHO’s governing bodies
Letter to Dr Tedros: Leadership and Advocacy for C-TAP
Statement to EB148 on expanding access to effective treatments for cancer and rare and orphan diseases, including medicines, vaccines, medical devices
Statement to EB148 on the COVID-19 response
Statement to EB148 on global strategy and plan of action on public health, innovation and intellectual property
Access to Internationally Controlled Essential Medicines in sub-Saharan Africa
2020